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ABSTRACT The means by which extracellular matrix density regulates three-dimensional capillary morphogenesis is unclear.
To study this phenomenon, we utilized a ﬁbrin-based in vitro assay in which a ﬁbroblast monolayer is plated atop a ﬁbrin gel
;2.5 mm away from endothelial cell-coated beads within the matrix. Increasing ﬁbrin density from 2.5 to 10 mg/ml resulted in a
threefold reduction in capillary network formation. However, distributing ﬁbroblasts throughout the matrix completely eliminated
this inhibitory effect, resulting in robustly vascularized matrices suitable for in vivo applications, as functional anastomoses
formed between the implanted tissues and host vasculature when implanted into immune-compromised mice. Dense matrices
did not stimulate ﬁbroblast-mediated matrix remodeling: differentiation into myoﬁbroblasts, matrix production, and protease
secretion were not enhanced by the dense condition. Instead, quantifying diffusivity of FITC-dextran (molecular mass 10, 40,
70, and 150 kDa) through ﬁbrin revealed a two- to threefold decrease within the 10 mg/ml matrices. Thus, distributing a
proangiogenic source (ﬁbroblasts) throughout the matrix stimulates capillary network formation by overcoming this diffusion
restriction due to signiﬁcantly reduced diffusion distances. Although roles for matrix stiffness and ligand binding density have
previously been identiﬁed, our results emphasize the importance of diffusion restrictions in limiting capillary morphogenesis.
INTRODUCTION
Changes in extracellular matrix (ECM) density occur in a
variety of pathologies. In cancer, tumors recruit nascent
vasculature that leaks the plasma protein fibrinogen into the
interstitial space (1). The accumulation and clotting of this
protein coupledwith a fibrotic response elicited from interstitial
cells (2) result in increased ECM density, which in turn alters
tissue mechanical properties, integrin adhesion sites, matrix
porosity (3,4), and ultimately vascular homeostasis.
For certain therapies, enhancing tissue vascularization is
desirable. For instance, the field of tissue engineering has
been limited to relatively thin tissues (,2 mm) because of
inadequate delivery of oxygen and nutrients to the core of
thicker tissues (5). One strategy to overcome this limitation is
to form a network of capillaries in vitro that, once implanted,
would rapidly anastamose with the host vasculature and
enhance nutrient delivery (6). However, a limitation of using
natural biomaterials is the requirement that they be compliant
enough to facilitate robust network formation yet stiff
enough to retain a desired three-dimensional (3-D) configu-
ration on implantation. Hence, we are interested in achieving
thorough vascularization within a dense/stiff matrix envi-
ronment. Although we and others have shown that en-
hancing the physical properties of the ECM restricts vascular
network formation (7–10), the underlying mechanisms in
three dimensions are still poorly understood.
To investigate the role of the ECM in 3-D capillary
morphogenesis, we have utilized a tissue culture model of
angiogenesis comprised of human umbilical vein endothelial
cell (HUVEC)-coated beads polymerized within a fibrin clot
and cocultured with a stromal cell (i.e., fibroblasts).
Normally, fibroblasts, which serve as a source of proangio-
genic factor(s) (11), are grown as a monolayer a fixed
distance (2.5 mm) from the HUVEC-coated beads. When the
distance between the HUVEC-coated beads and the fibro-
blast monolayer exceeds a critical threshold, capillary
formation is severely attenuated, suggesting that diffusion
limitations of fibroblast-derived proangiogenic factor(s) are
important (12). Maintaining this distance constant while
increasing the fibrin density from 2.5 to 10 mg/ml (thus
increasing stiffness sevenfold) significantly reduces capillary
morphogenesis as well (8).
We hypothesized that distributing fibroblasts in three
dimensions within a dense fibrin matrix would also stimulate
angiogenesis and that the mechanism could involve one or
more of the following: 1), myofibroblast-mediated matrix
remodeling; 2), stimulation of ECM (collagen or fibronectin)
production; 3), enhanced fibrinolytic activity; or 4), enhanced
diffusive transport of fibroblast-derived proangiogenic factors
as a result of reduced diffusion distances. Our data demon-
strate that, indeed, distributing fibroblasts in three dimensions
significantly enhances angiogenesis and completely elimi-
nates the inhibitory effect of increasing fibrin density. Further,
these robustly vascularized tissues inosculate with host vessels
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when implanted within immune-compromised mice and
remain functional nearly 1 month postimplantation.
Distributing the fibroblasts in three dimensions does not
enhance myofibroblast differentiation, ECM production, or
ECM degradation. Instead, increasing the density of fibrin
significantly restricts the effective diffusivity of putative angio-
genic factors, demonstrated by the reduced diffusion of
fluorescein-labeled dextran (molecular mass range of 10–150
kDa).Our results suggest that changes in the density of structural
proteins within the ECM, such as fibrin, may play a critical role
in the regulation of capillary morphogenesis by limiting the
diffusional transport of proangiogenic macromolecules.
METHODS
Fibrin tissue construction
Cytodex microcarrier beads (Sigma-Aldrich, St. Louis, MO) were sterilized
and prepared for seeding by washing repeatedly with Endothelial Growth
Medium (EGM-2, Cambrex, East Rutherford, NJ). Ten thousand such beads
were combined in 5 ml of EGM-2 with 4 3 106 HUVEC (p3) and agitated
periodically over 4 h in an inverted T-25 culture flask. HUVEC were
obtained freshly from umbilical cords as previously described (12). After
4 h, 5 ml of fresh medium was added to the cell-bead mixture. The total
volume was then transferred to a new T-25 and incubated in standard cell
culture position.
The next day, bovine fibrinogen (Sigma) solutions of the desired
concentrations (2.5, 5, or 10 mg/ml) were prepared in serum-free EGM-2
and sterile filtered. After addition of 5% fetal bovine serum, 500 ml of this
solution (with 50K normal human lung fibroblasts used before p10 for
distributed fibroblast conditions) was mixed with ;100 HUVEC-coated
beads and polymerized with 10 ml of thrombin (Sigma, 50 U/ml) in a single
well of a 24-well plate per tissue. At this point, the tissues were left
undisturbed for 5 min at room temperature before incubation for 25 min at
37C and 5% CO2 to facilitate gelation. For monolayer conditions, 25K
fibroblasts/ml were suspended in EGM-2 and plated on top of the fibrin gel.
Medium was changed the following day, and every other day thereafter. We
have previously shown that 3-D tissue constructs prepared via these methods
support the formation of capillary networks with well-defined lumens (8).
Tissue implantation within immune-compromised
mouse and immunohistochemistry
Robustly vascularized 7-day-old 10 mg/ml fibrin gels were implanted
subcutaneously intomice containing disrupted recombination activating gene
2 (Rag2; Taconic Farms, Oxnard, CA). Rag2 knockouts fail to produce
mature T or B lymphocytes and thus are ideal for human cell transplantation.
Surgeries were performed according to the NIH guideline for laboratory
animal usage and our approved institutional protocol.Micewere anesthetized
via abdominal injection of a ketamine/xylazine cocktail. The dorsal area of the
animalwas shaved and disinfected. An incisionwasmade through the dermis,
and a pouch was created between the skin and underlying muscle. Tissue
constructs were inserted into the pouch (two per animal). Analgesia was
provided abdominally at the completion of surgery. The animals were
sacrificed, and the tissues were harvested, 4 weeks after implantation. The
fibrin tissues were comprised of HUVECs coated on dextran beads with
fibroblasts distributed throughout as described above. The tissue was placed
in a PDMSmold (10 mm diameter, 3 mm depth) before implantation to limit
diffusion of nutrients to the top surface of the tissue.
After 4weeks of implantation, animals were sacrificed, and tissue constructs
were removed,fixedovernight in 10%neutral buffered formalin, and embedded
in paraffin. Hematoxylin and eosin (H&E) and immunohistochemical (IHC)
stainswere performedon4-mmtissue sections. IHCstainwith antihumanCD31
(1:200) (Dako, Cambridgeshire, UK) was carried out using the DakoCytoma-
tion EnVision System-HRP (DAB) followed by a light H&E stain.
Transduction of HUVEC and NHLF
HUVEC and normal human lung fibroblast (NHLF) were transduced with
monomeric red fluorescent protein (RFP) or green fluorescent protein (GFP)
using the Phoenix Retrovirus Expression System (Orbigen, San Diego, CA).
The pBMN-GFP vector was obtained commercially (Orbigen). The RFP
vector was constructed by inserting the RFP gene of pCDNA3-mcherry
(kindly provided by Dr. Roger Tsien, University of California, San Diego)
into the pBMN-Z vector (Orbigen). Stable transduction of HUVEC and
NHLF were achieved using methods described previously (13). Daily viral
transductions were performed 6 h per day for a total of 4 days. The
percentage of cells expressing GFP or RFP was 60–80%, as quantified by
fluorescence-activated cell sorting.
Imaging and quantiﬁcation of total network length
Tissues containing GFP-infected HUVECwere imaged at day 7 postassembly
via fluorescence microscopy with an Olympus 1X51 equipped with a 100-W
high-pressure mercury burner (Olympus America, Center Valley, PA) and a
QImaging QICAM 12-bit Color Fast 1394 camera (QImaging, Surrey, BC).
QCapture Pro Software was used for image acquisition (QImaging). Five
beads per condition were randomly imaged at low power (43) for each
experiment (over three experiments to generate a sample size of 15).
Methods to quantify total network length have been described previously
(8). Briefly, vessel segments for each bead were traced, counted, and
quantified using open-source image processing software (NIH ImageJ,
National Institutes of Health, Bethesda, MD). The resulting values of total
network length and total number of vessel segments for all 15 beads per
condition were then tabulated and averaged.
Fibrin gel lysing, zymography, and
Western blotting
For each condition, three fibrin tissues, each containing ;100 HUVEC-
coated beads, were pooled together and digested via homogenization and
sonication in 300 ml of ice-cold Garner buffer (50 mM Tris, pH ¼ 7.5, 150
mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100). Any
remaining solids (undigested fibrin and cell membrane) were removed by
centrifugation at 14,000 rpm for 10 min at 4C. Protein concentration of the
resulting supernatant was quantified via bicinchoninic acid assay (Pierce
Biotechnology, Rockford, IL).
For Western blotting, 40 mg of protein per condition was electrophoresed
under reducing conditions and transferred to a PVDF membrane. Blots were
probed with either a mouse monoclonal antibody against human a-smooth
muscle actin (a-SMA; 1:1000, Sigma) or a mouse polyclonal antibody
against human fibronectin extra domain-A (ED-A; 1:450, Abcam, Cam-
bridge, MA), followed by incubation with a horseradish peroxidase-
conjugated antimouse secondary antibody (1:10,000, Santa Cruz Biotech-
nologies, Santa Cruz, CA). Membranes were washed for 1 h before detection
via an enhanced chemiluminescence detection system. Bands were identified
by comparing to a molecular mass ladder (Santa Cruz).
For gelatin zymography, precast Novex zymogram gels (10% Tris-Glycine
gel with 0.1% gelatin, Invitrogen, Carlsbad, CA) were loaded with 25 mg of
protein per condition and separated under nonreducing conditions. Gels were
renatured overnight in a 50 mM Tris-HCl (pH¼ 8.0), 5 mMCaCl2, and 2.5%
TritonX-100 solution.After renaturing, zymogramswere incubated at 37C for
24 h in enzyme activation buffer (125 mM Tris-HCl, pH ¼ 7.5, with 5 mM
CaCl2). Gelswere thenCoomassie stained for 1 h and destained 15min twice in
10% acetic acid and 20% ethanol. MMP-2 and MMP-9 bands were identified
with an MMP-2/-9 standard (Chemicon, Temecula, CA).
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Plasminogen zymography was conducted to assess the activities of
urokinase plasminogen activator (uPA) and tissue plasminogen activator
(tPA) activities in a fashion nearly identical to gelatin zymography,
described above. In this case, gels were cast with 1% plasminogen (1 U/ml,
Sigma), and CaCl2 was not added to the renaturing or activation buffers;
5 mM EDTA was added to the activation buffer to chelate divalent cations
that typically serve to activate MMPs.
Confocal imaging
Multiphoton images were obtained as previously described (14) using a
commercially available laser scanning multiphoton microscope (LSM 510
Meta, Zeiss, Jena, Germany). Briefly, 2.5, 5, and 10 mg/ml fibrin gels
containing 100K NHLF/ml (300 ml volume) were polymerized in No.
1 thickness, 8-well borosilicate chamber slides and maintained in EGM-2
until the appropriate time point. Live tissues were then scanned using a 403,
1.3 numerical aperature oil-immersion objective. Backscattered second
harmonic generation (SHG) and two-photon fluorescence (TPF) signals
were simultaneously obtained in two separate channels by excitation with a
780-nm wavelength. SHG was collected using a 387- to 398-nm bandpass
filter, whereas TPF was collected using a 480- to 520-nm bandpass filter.
Reflectance of fibrin was imaged by excitation with a 543-nm laser and use
of a linepass filter to collect the resulting signal at 505 nm. Pinhole size and
laser power were kept constant throughout the imaging. Three different
locations within at least two tissues per condition were scanned at days 7 and
14. Images were then compared to determine whether any significant SHG
signal existed extracellularly in any of the conditions probed.
Sircol collagen assay
ASircol soluble collagen assay (Biocolor, Newtownabbey, Northern Ireland)
was performed according to manufacturer’s protocol. Briefly, at each time
point, three fibrin gels per conditionwere washed once with PBS, collected in
15-ml centrifuge tubes, weighed (to extrapolate gel volume), and stored at
80C. At the time of the assay, gels were thawed, and pepsin-soluble
collagens were extracted from the gels by overnight incubation at room
temperature in 1.5 ml of a 0.5M acetic acid and 5 mg/ml pepsin solution. The
following day, tubeswere centrifuged, and 100ml of the resulting supernatant
was added to a 1.5 ml microcentrifuge tube. One milliliter of Sircol dye
reagent was added to each tube and mixed for 30 min. The collagen-dye
complex was subsequently recovered by centrifuging at 14,000 3 g for 10
min, draining the supernatant, and removing any remaining unbound dye
solutionwith an absorbent tissue. Alkaline dye solution (0.5ml) was added to
the isolated pellet and vortexed until well mixed. Collagen standards as well
as samples fromeach time point and conditionwere added in duplicate to a 96-
well plate. Absorbance of each sample at 540 nm was measured (after
blanking) and averaged using a Benchmark Microplate Reader (Bio-Rad
Laboratories, Hercules, CA). The final amount of collagen (weight) for each
sample was obtained from its absorbance values by comparison to a collagen
standard curve (R2. 0.99) with correction for all previous dilutions. For each
assay, values obtained were normalized by those obtained for an acellular
fibrin gel of equal concentration.
Microﬂuidic diffusion culture platform fabrication
Diffusion chambers were fabricated with PDMS using soft lithography and
replica molding. Photolithography was utilized to pattern one layer of
negative photoresist, SU-8, on a silicon wafer, resulting in a master
comprised of two wells separated by a number of channels that have a width
of 500 mm, a height of 300 mm, and a length of 3 mm. A prepolymer mixture
of Sylgard 184 was cast and cured onto the negative replica, as previously
described (15). After curing, the PDMS was peeled away from the master,
and reservoirs were cut out with a surgical blade. Next, both the diffusion
device and a No. 1 cover slip were plasma treated using a Harrick Plasma
Cleaner (Harrick Plasma, Ithaca, NY) to bond them together irreversibly.
Fibinogen stocks (2.5 and 10 mg/ml in PBS) were aliquoted and
maintained at 20C to eliminate batch-to-batch variability of the polymer-
ized gels. For each experiment, the appropriate aliquot was thawed, mixed
with thrombin, and immediately pipetted near the channel edge of the well.
The solution wicked into the neighboring channels. After the fibrinogen was
allowed to clot within the channels for 5 min at room temperature and another
25 min at 37C, 300 ml of PBS was added to each well, and the device was
incubated overnight to allow the hydrogel network to swell appropriately.
Diffusion experiments and quantiﬁcation of Deff
Diffusion experiments were monitored with a Nikon TE300 microscope
(Nikon,Melville, NY) equippedwith amotorized stage and a xenon lamp. PBS
was removed from the microfluidic device before mounting so that equal and
accurate volumes could be loaded in eachwell. After mounting, stage positions
were chosen such that the ‘‘source’’ reservoir, the reservoir-channel interface,
and a substantial portion of the channel were contained in one low-
magnification (43) field of view. Multiple stage positions were chosen such
that diffusion through multiple channels of the device could be monitored. At
this point, 300 ml of PBS was added to the ‘‘sink’’ reservoir (not contained in
the field of view), and 300ml of a 100mg/ml solution of fluorescein-conjugated
dextran particles (molecular mass of either 10, 40, 70, or 150 kDa) were
carefully pipetted into the ‘‘source’’ well to minimize generation of convective
currents. Time-lapse imaging commenced immediately after the addition of the
dextran particles using a 488-nm excitation filter, and images were taken every
30 s for a total of 30 or 60 min depending on the observed rate of diffusion.
Image stacks were generated from the described time-lapse experiments
using Metamorph software (Universal Imaging/Molecular Devices Corpo-
ration, Union City, CA). Three parallel linescans spaced 60 pixels apart
situated in the middle of the channel were averaged, and the resulting
intensity profiles (over distance) were logged onto a spreadsheet at five
equally spaced time points (starting at t ¼ 0). The x position of the source
reservoir-channel interface was set as x ¼ 0, and the coordinates throughout
the rest of the channel were rescaled appropriately.
The effective isotropic diffusion coefficient, Deff, was extracted from the
acquired data by assuming that the channel could be approximated as a one-
dimensional, semiinfinite slab and solving Fick’s second law:
@C
@t
¼ Deff @
2
C
@x
2 (1)
given the following initial condition and boundary conditions:
t ¼ 0 : C ¼ 0 for all x. 0 (2)
x ¼ 0 : C ¼ Co for all t. 0 (3)
x/N : C/0 for all t. 0: (4)
The following solution was then obtained:
C ¼ Co  Co
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p
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e
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Differentiating Eq. 5 with respect to t and rearranging gives the following
relation at x ¼ x0:
ln
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Time derivatives at t ¼ tn (n ¼ 1, 2, 3, or 4) were calculated using a finite
difference formula:
@C
@t
¼ Cn1 1  Cn
tn1 1  tn ; (7)
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where Cn is the measured intensity at time tn. The left side of Eq. 6 was
plotted against 1/t, and a straight line was fitted to the data using a least-
squares procedure. The diffusivity Deff was estimated from the slope of the
line, x2o=4Deff . This was repeated at m different locations along the length
of the channel at which @C=@t were positive. Deff values from the best-fit
range with R2 $ 0.99 were averaged to obtain the Deff value for that
experiment.
Statistical analysis
Statistical analyses were performed using SigmaStat 3.5 (Systat Software,
San Jose, CA). All statistical comparisons were made by performing a one-
way analysis of variance (ANOVA), followed by one of the following
pairwise multiple comparison procedures: Holm-Sidak method (for vessel
network quantification) or Student-Newman-Keuls method (for quantifica-
tion of Deff). Statistical significance was assumed when p , 0.05. Data are
reported as mean 6 SD.
RESULTS
Distributing ﬁbroblasts interstitially negates the
inhibitory effect of matrix density on capillary
network formation
GFP-transduced HUVECs cultured on microcarrier beads
within 2.5 mg/ml fibrin gels overlaid with a fibroblast
monolayer form extensive capillary networks by day 7 (Fig.
1 A). Although increasing matrix density to 5 mg/ml did not
significantly affect network formation (Fig. 1 B), total network
length was reduced significantly (about threefold) in 10mg/ml
matrices (Fig. 1, C and G: 5231 6 1884 mm for 2.5 mg/ml
gels versus 17346 842 mm for 10 mg/ml gels). This decrease
in total capillary network length is caused primarily by a
decrease in the number of vessel segments formed (Fig. 1 H).
A denser matrix may retard the diffusion of soluble
mediators (11); thus, we distributed fibroblasts throughout
the fibrin matrix (as opposed to a monolayer a fixed distance
away) before polymerization to reduce the diffusion dis-
tance. Conventional brightfield microscopy did not allow
resolution of these networks (Fig. 1, D–F, inset) because of
an inability to distinguish fibroblasts from budding vessels.
To overcome this, HUVECs were transduced with a GFP-
expressing retrovirus (Fig. 1, D–F), facilitating network
visualization. Fibroblast distribution led to a drastic
upregulation of network formation for all matrix densities,
and total network length no longer decreased significantly
with increasing fibrin density (Fig. 1 G). Network formation
was increased;2.3-fold in 2.5 mg/ml matrices,;2.9-fold in
5 mg/ml matrices, and ;5.7-fold in 10 mg/ml matrices (Fig.
1 G). This increase was attributable to a greater number of
capillary segments formed (Fig. 1 H). The average segment
FIGURE 1 Distributing fibroblasts
throughout the matrix abrogates the
inhibitory effects of increased fibrin
concentration on capillary network for-
mation. Representative images of iso-
lated microcarrier beads initially coated
with GFP-transduced HUVEC within
(A) 2.5, (B) 5, and (C) 10 mg/ml fibrin
matrices (day 7). Cultures contained
an overlying fibroblast monolayer. A
488-nm excitation reveals the capillary
network in fibrin gels containing dis-
tributed fibroblasts instead of a fibro-
blast monolayer in (D) 2.5, (E) 5, and
(F) 10 mg/ml matrices (inset: bright-
field imaging was not suitable to dis-
tinguish capillaries from fibroblasts).
Scale bars ¼ 200 mm. Fifteen beads
over three separate experiments were
quantified at day 7 for (G) total network
length and (H) total number of vessel
segments. In G, *p , 0.05 and **p ,
0.01 when comparing 2.5 and 5 mg/ml
conditions to the 10 mg/ml condition.
In H, *p , 0.05 when comparing the
2.5 mg/ml condition to the 10 mg/ml
condition. yyyp , 0.001 when com-
paring the distributed condition to the
monolayer condition for the respective
fibrin density.
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length did not deviate significantly from those measured for
the fibroblast monolayer conditions (e.g., 211.5 mm for 10
mg/ml monolayer gels versus 230.1 mm for 10 mg/ml gels).
Capillary networks formed within dense,
ﬁbroblast-distributed gels are functional in vivo
To determine whether the enhanced capillary networks
formed within 10 mg/ml fibrin gels are viable, gels initially
constructed with HUVEC-coated beads and distributed
fibroblasts were cultured for 7 days and implanted subcu-
taneously on the dorsal surface of immune-compromised
mice. Removing these tissues revealed that functional
anastomoses had formed between the HUVEC-lined vessels
and those of the host. Further, capillaries remained functional
for 4 weeks, as evidenced by the presence of red blood cells
within vessels near a dextran bead (Fig. 2 A) and human
CD31-positive vessels perfused with blood (Fig. 2 B).
Vessels in the host tissue surrounding the implant, although
perfused, did not stain positive for human CD31, demon-
strating that the antibody used did not cross-react (Fig. 2 C).
Fibrin tissues containing only HUVEC showed no evidence
of perfusion with host red blood cells (Fig. 2 D).
Fibroblast differentiation into myoﬁbroblasts
proceeds independently of ﬁbrin density
To explore the possiblemechanisms bywhich the distribution
of interstitial cells reverses the inhibitory effect of increased
matrix density on capillary network formation, we first sought
to determinewhether distributingfibroblasts throughout denser
matrices promoted their differentiation into myofibroblasts.
A defining characteristic of myofibroblasts is that they
express a-SMA (16), and the extent of this expression is
directly correlated to the amount of tractional stress the
cells can exert to remodel their matrix (17).
Fig. 3, A–C, provides qualitative evidence that fibroblasts
(transduced with GFP retrovirus) were intimately interacting
with sprouting HUVEC capillaries (transduced with RFP
retrovirus) at all fibrin densities. This periendothelial behavior
is typical of cells of mesenchymal or smooth-muscle origins,
which are characterized by the expression of a-SMA (18).
Western blotting for a-SMA and for cellular fibronectin
containing the ED-A splice variant, an inducer of myofibro-
blast maturation (16), demonstrated enhanced myofibroblast
differentiationwith time in culture (day 14 comparedwith day
3) but did not show any dependence on fibrin concentration
(Fig. 3, D and E). The presence of HUVEC did not
appreciably alter these expression patterns (data not shown).
Collagen synthesis and secretion of proteins
involved in the ﬁbrinolytic cascade are unaffected
by increased ﬁbrin density
We next sought to determine whether distributing the
fibroblasts enhanced matrix protein secretion and/or degra-
dation, and thus capillary sprouting, within the dense fibrin
condition. Fig. 4 A shows a representative image of a single
live NHLF at day 14 within a 5 mg/ml fibrin matrix. From
comparing the SHG and TPF signals, it is clear that the vast
majority of collagen (excited by SHG (19)) is confined
pericellularly (shown by the close association of SHG and
TPF signals). Reflectance (REF) imaging shows the interac-
tion of this cell with the surrounding matrix. For all fibrin
conditions, a signal from collagen, though present, was
primarily confined to the pericellular region (data not shown).
FIGURE 2 Implanted high-density fibrin tissues with
distributed fibroblasts and mature capillaries develops
functional anastomoses with mouse. (A) H&E stain of a
high-density (10 mg/ml) fibrin tissue with distributed
fibroblasts and a developed capillary network originating
from HUVEC-coated dextran beads demonstrates capillar-
ies with mouse red blood cells (black arrow) in the lumen
near the dextran bead (DB) 28 days postimplant. (B) IHC
stain of human CD31 identifies human endothelial cells
(HUVEC, in brown) lining vessels perfused with mouse
red blood cells (black arrows). Interstitial cells are seen
surrounding the mature capillary (*). (C) IHC stain of
mouse tissue with antihuman CD31 demonstrates lack of
cross-reactivity (black arrow). (D) H&E stain of a negative
control tissue comprised of randomly distributed HUVECs
in 10 mg/ml fibrin (no fibroblasts). The border between the
implanted tissue (IT) and the mouse tissue (MT) is visible.
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Quantitative confirmation of this observation was accom-
plished through the Sircol collagen assay to determine levels
of pepsin-soluble collagen. Levels of recently synthesized
collagen did not vary significantly from acellular fibrin gels
(negative control) for any condition probed and accordingly
did not vary significantly with time or fibrin density (Fig. 4 B).
In addition to collagen synthesis, neither fibroblast
cultures nor HUVEC-fibroblast cultures demonstrated ap-
preciably altered fibrinolytic capacities in response to
increased matrix density. The activities of MMP-2 and -9
were not enhanced early on (day 3) or late (day 14) as fibrin
density increased in cultures containing either fibroblasts
only, HUVECs with an overlaid fibroblast monolayer, or
HUVECs with distributed fibroblasts (Fig. 4 C). Activities of
uPA and tPA, which activate plasminogen to the fibrinolytic
serine protease plasmin, displayed similar trends (Fig. 4 D).
Dense ﬁbrin matrices restrict diffusive transport
of 10-, 40-, 70-, and 150-kDa molecular
mass markers
Alterations in the diffusion of soluble mediators represent an
alternate mechanism possibly accounting for the enhance-
ments in capillary formation observed when fibroblasts are
distributed throughout the interstitial space. To explore
diffusive transport, we utilized soft-lithography to construct
a two-well, multichannel microdevice within which fibrin
gels could be polymerized (illustrated schematically in Fig. 5
A, actual device shown in Fig. 5 B). Fig. 5, C and D,
demonstrates that a FITC-conjugated 10-kDa molecular
mass marker diffuses markedly faster through channels
containing 2.5 mg/ml fibrin (Fig. 5 C) than in channels
containing 10 mg/ml fibrin (Fig. 5 D). Intensity profiles
versus distance through the channel were generated at
separate time points, revealing transport behavior consistent
with Fick’s second law (Fig. 5 E). Ten mg/ml fibrin matrices
yielded a significant decrease in Deff across the entire range
of FITC-dextran molecular mass markers tested (represented
by their hydrodynamic radius, RH) compared with 2.5 mg/ml
gels (Fig. 5 F). The dependence of Deff on RH (extrapolating
from the Deff value obtained for the 10-kDa marker) for each
fibrin concentration was compared with values predicted by
the Wilke-Chang empirical relation and the Stokes-Einstein
equation (Fig. 5 F), which state that diffusion through an
aqueous medium is inversely dependent on the RH of the
diffusing molecule to the power of 1.8 or to the power of 1,
respectively (20,21).
DISCUSSION
The role of the ECM in regulating capillary morphogenesis is
only partially understood, and a more complete understand-
ing of its role is necessary to facilitate therapeutic applica-
tions to aid tissue engineering approaches and combat
pathologic processes such as cancer and fibrosis. Utilizing a
truly 3-D in vitro model of angiogenesis, we have demon-
strated that increasing the density of fibrin significantly
inhibits the formation of capillary networks. This restriction
can be overcome by distributing a stromal cell (in this study,
fibroblasts) throughout the matrix (Fig. 1).
We previously postulated that 10 mg/ml fibrin matrices,
with compressive stiffness values on a par with that of
skeletal muscle, would make useful tissue engineering
scaffolds (8). The functionality of these dense, vascularized
tissue constructs was confirmed by implanting them within
immune-compromised mice and demonstrating perfusion
within HUVEC-lined vessels as a result of anastomosing
with the host vasculature (Fig. 2, A and B). Fibroblasts have
FIGURE 3 Myofibroblast differentiation is not modu-
lated by fibrin density. RFP-infected HUVECs form
capillaries when cocultured with GFP-infected fibroblasts
distributed throughout the matrix. At day 7, fibroblasts are
in close proximity to the developing capillary (white
arrowheads) at (A) 2.5, (B) 5, and (C) 10 mg/ml
(representative images). Scale bars ¼ 40 mm. This
pericyte-like behavior is indicative of a smooth muscle
cell-like phenotype. (D and E) Fibroblasts express markers
indicative of myofibroblast differentiation. (D) a-SMA
and (E) whole fibronectin (FN) containing the extra
domain-A (ED-A) splice variant as well as ED-A frag-
ments for the indicated matrix conditions at day 3 and day
14. Immunoblots are representative of three separate
experiments.
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previously been shown to support the formation of patent
capillaries in vitro (11), and they may help induce vessel
penetration in vivo, as tissues lacking these cells provided
no evidence of perfusion (Fig. 2 D). In addition, although
collagen gels seeded with HUVECs have been shown to
anastomose with mouse vasculature (13,22), this is the first
study todemonstrate thatmatureHUVECcapillaries supported
by fibroblasts in a dense fibrin gel will inosculate with mouse
vasculature as well. Whereas future studies will focus on how
prevascularization affects oxygen delivery and the survival of
implanted cells, this study focused on the underlying mecha-
nism of how distributing fibroblasts can overcome a dense
matrix to stimulate capillary formation in vitro.
We initially hypothesized that increased matrix remodel-
ing by the fibroblasts was responsible for this behavior.
Physiologically, fibroblasts differentiate into the highly
contractile myofibroblast phenotype in response to a variety
of factors during wound healing (16,23), including increases
in matrix stiffness (24) and TGF-b1 stimulation (25,26). The
extent of this differentiation, marked by levels of a-SMA
expression, is directly proportional to the tractional force
exerted by myofibroblasts (17), potentially enabling these
cells to pull apart the denser matrix and facilitate capillary
penetration. However, although fibroblast differentiation
into mature myofibroblasts was observed as early as day 3,
levels of a-SMA expressed by these cells were not sensitive
to changes in fibrin density through day 14 (Fig. 3 D).
Furthermore, the ability of fibroblasts to act in a pericyte-like
fashion when distributed throughout the matrix (Fig. 3, A–C)
is also unlikely to contribute to increases in network lengths,
given our evidence that this occurs across all matrix
densities. Additionally, pericyte incorporation is a stabilizing
mechanism that instead prevents capillary branching at sites
of association via local MMP down-regulation (27,28).
In the absence of density-induced upregulation of myofi-
broblast-mediated matrix remodeling, modification of the
fibrin matrix through ECM protein deposition or proteolysis
was examined. Fibronectin containing the ED-A fragment is
not only an inducer of myofibroblast differentiation, but
fibronectin fragments have been shown to enhance endothelial
cell proliferation and migration (29). Meanwhile, fibroblast-
mediated collagen deposition is a crucial mediator of capillary
FIGURE 4 Collagen secretion, gela-
tinase activity, and plasminogen acti-
vator activity do not depend on fibrin
density. Representative confocal image
of a fibroblast at day 14 within a 5 mg/
ml fibrin gel. (A) Second harmonic
generation (SHG) reveals an intracellu-
lar collagen-laden signal. Two-photon
fluorescence (TPF) reveals the fibro-
blast, whereas the REF image reveals
cell-matrix interactions. Scale bars ¼
50 mm. (B) A quantitative collagen
(Sircol) assay demonstrates that levels
of newly synthesized (pepsin-soluble)
collagen do not significantly change
among conditions investigated. (C)
Gelatin and (D) plasminogen zymo-
graphy do not reveal detectable increases
in the activities of MMP-9, MMP-2,
tPA, or uPA at days 3 or 14 with in-
creasing fibrin density among the indi-
cated conditions. Zymograms shown are
representative of three separate exper-
iments.
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morphogenesis in other in vitro systems (30). In this system,
fibronectin deposition (Fig. 3 E) and collagen secretion (Fig. 4,
A and B) were unchanged with fibrin density; in fact, secreted
levels of collagen appeared insignificant.
MMP-2 and -9 are soluble members of the MMP family
that are secreted by cells in the interstitial space and act in a
variety of capacities to promote angiogenesis (31). Specifi-
cally, MMP-2 activation by membrane-bound proteases at the
endothelial cell surface results in matrix proteolysis and
activation of other MMPs, including MMP-9 (32), whereas
active MMP-9 itself is fibrinolytic (33) and also liberates
matrix-bound VEGF from the matrix (34). In our study,
activities of these MMPs were not modulated by fibrin density
(Fig. 4 C). Similarly, functions of the soluble serine protease
plasmin, activated at the cell surface via uPA and elsewhere
by fibrin-bound tPA, include fibrin degradation and MMP
activation (35). Levels of uPA and tPA activities were
unchanged despite increased fibrin density (Fig. 4 D).
It is important to note, however, that pericellular activity is
critical to mediating capillary formation (36,37) and that the
amounts of active MMP-2/-9, uPA, and tPA measured in our
system reflect bulk levels present throughout the matrix.
These measurements are not necessarily indicative of en-
zyme activity in the immediate vicinity of the capillary.
Nonetheless, the notion that robust sprouting takes place in
low-density monolayer cultures but not in high-density
cultures despite similar levels in activity of these fibrinolytic
activators/agents (Fig. 4, C and D) suggests that insoluble
cues (e.g., stiffness) derived from increased matrix density
are likely not modulating fibroblast secretion of protease
precursors. Rather, these data suggest that transport of latent
gelatinases and plasminogen/plasmin is hindered in the 10
mg/ml matrices, resulting in reduced levels of these soluble
proteins reaching the capillaries.
After obtaining these results, we pursued an alternate
hypothesis and chose to focus on limitations in the transport
of macromolecules that may result from increasing fibrin
concentration from 2.5 to 10 mg/ml. Because interstitial
tissue is inherently heterogeneous (38), analyzing diffusion
over short length (order of micrometers) and time scales
(order of seconds) through interstitial tissue reveals two
distinct diffusing populations as a result of their interactions
with the aqueous and viscous phases of the tissue (39). We
have measured diffusions over length (order of millimeters)
and timescales (order of minutes) that capture both of these
phases (Fig. 5 E) and as such have termed the measured
FIGURE 5 Fibrin density signifi-
cantly influences molecular diffusivity.
(A) Fibrinogen solutions at 2.5 or 10 mg/
ml were wicked by capillary action into
500 3 300 3 3000 mm channels and
clotted as shown in this SolidWorks
representation. (B) The actual device
loaded with red dye. Imaging 10 kDa
FITC-dextran movement through these
channels reveals restricted diffusion of
the marker in a (D) 10mg/ml gel versus a
(C) 2.5 mg/ml gel at a sample time point
(t¼ 25min). Line scanning of fluorescent
marker diffusive transport through the
channel at discrete time points produced
(E) an intensity profile over time similar
to that described by Fick’s second law.
(F) Values of the molecular diffusivity,
Deff, for 10-, 40-, 70-, and 150-kDa
markers in 2.5 (gray data points) and 10
mg/ml (black) fibrin gels were quantified
as described in Methods. Anticipated
dependence of the diffusivity on RH was
extrapolated from the measured 10-kDa
values using the Wilke-Chang empirical
model (dashed lines) and the Stokes-
Einstein equation (dotted lines). Data
points are representativeof seven separate
experiments quantified in triplicate. As-
terisk denotes statistical significance
(*p , 0.05) between 10-kDa molecular
mass markers and all others within the
samefibrin concentration,Daggerdenotes
significance (yp, 0.05) among different
fibrin concentrations for markers with
the same molecular mass/RH.
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transport phenomenon Deff. The effective diffusion coeffi-
cient (Deff) obtained for each molecular mass marker (10, 40,
70, and 150 kDa) for both fibrin conditions tested was
effectively bounded by the Wilke-Chang correlation and the
Stokes-Einstein relationship (Fig. 5 F). Both equations
describe binary (solute A in solvent B) diffusion in liquids
(20,21). The former effectively predicts that D is inversely
proportional to solute R1:8H , whereas the latter predicts that D
is inversely proportional to RH. D would thus be expected to
decrease with increasing molecular mass because increased
molecular mass implies increased RH.
The reduced diffusivity when molecular mass (and thus
RH) is held constant but fibrin concentration is increased can
be attributed to the increased viscosity of the solution. Both
the Wilke-Chang and Stokes-Einstein relationships predict
that D is inversely proportional to solvent (i.e., fibrin matrix)
viscosity. Increasing the fibrin content drastically increases
the fiber and branchpoint densities while not significantly
altering fiber diameter (4). This increases the viscous
component of the hydrogel and is likely responsible for the
observed decreases in Deff over all molecular masses tested.
As the concentration of fibrin increased from 2.5 to 10 mg/ml
(fourfold), dextran Deff was reduced two- to threefold.
Because the Stokes-Einstein equation specifies an inverse
relationship between D and solvent viscosity, a 10 mg/ml gel
is thus expected to be nearly three times more viscous than a
2.5 mg/ml gel. This is indeed the case when the clottable
fraction of these gels is considered (40).
There is precedence in the literature for increased matrix
density adversely affecting transport properties. A threefold
increase in fibrin density decreases the aqueous permeability
of the hydrogel by over an order of magnitude (41). Other
hydrogels exhibit similar behavior. For example, an increase
in collagen concentration of a similar magnitude to the
increase in fibrin concentration tested in this study reduces
the D by 50% as RH increases (42). Comparable results have
also been obtained in vivo with increased collagen content
within the tumor interstitium (43) or by comparing transport
within neoplastic tissue to that within relatively dense
granulation tissue (44). Moreover, variations in structures
among discrete hydrogel types can influence measured
values of D; relatively broad variations have been measured
among agarose, alginate, fibrin, and gelatin (45). Finally, our
own research group has demonstrated that capillary forma-
tion in this model is significantly reduced when the distance
separating the fibroblast monolayers is increased to more
than 3 mm (12), suggesting a significant diffusion limitation
of a fibroblast-derived mediator.
The observed reduction in molecular-level diffusive
transport is significant in our system only if the concentration
profile of growth factors was significantly altered in the time
and physical dimensions of our experiments. To simulate the
functional result of decreasing Deff, Eq. 1 was solved by
applying the following initial and boundary conditions to
simulate the HUVEC-fibroblast monolayer culture:
t ¼ 0 : C ¼ Co for all z$ 0 (8)
z ¼ 0 : D@C
@z
¼ FP for all t. 0 (9)
z ¼ L : C ¼ 0 for all t. 0: (10)
These conditions simulate a soluble macromolecule (e.g., a
protein), initially at a concentration Co (Eq. 8), produced at a
constant rate, Fp, at the gel surface (z¼ 0) by fibroblasts (Eq.
9) and consumed when it reaches the HUVEC by diffusion at
the bottom of the gel (a distance L away, Eq. 10). Solving for
these conditions generates the following solution for the
concentration profile of a factor:
C¼ 2
Llm
Cosin

mp
2

 FP
lm
 
cosðlmzÞ3el
2
mDeff tFPðzLÞ;
(11)
wherem¼ 1, 3, 5, . . ., lm ¼ mp=2L are the eigenvalues, and
C is the concentration of the macromolecule in the gel as a
function of position and time. Because the identities of the
fibroblast-derived factors that facilitate angiogenesis within
this system are unknown (11), reasonable values were
chosen for the following parameters: L was set at 0.25 cm,
Fp ¼ 4.94 3 1019 mol/s (46), and Co ¼ 0 for a solely
fibroblast-derived factor. Fig. 6 plots C as a function of
position and time (each line represents a 12-h interval),
where Deff ¼ 106 cm2/s (Fig. 6 A), Deff ¼ 107 cm2/s (Fig.
6 B), and Deff ¼ 108 cm2/s (Fig. 6 C). The resulting
gradients demonstrate that the time to reach steady state (i.e.,
achieve a concentration profile that does not vary with time)
shifts from hours (Deff ¼ 106 cm2/s) to days (Deff ¼ 107
cm2/s) to over a week (Deff ¼ 108 cm2/s). Although rapidly
achieving steady state is not necessarily a requirement for
capillary morphogenesis, it is indicative of the time scale
over which diffusion of a given macromolecule occurs.
Reduced diffusivity in denser matrices thus signifies delayed
availability of proangiogenic molecules as a result of
hindered transport. Further, in light of recent findings
that stable VEGF concentration gradients generated by
myoblasts with lower Fp promote far more normalized
angiogenesis compared with myoblasts heterogeneously
producing more prolific levels of VEGF (46), the time
required to achieve a steady state (i.e., stable) concentration
gradient for a given factor may be pertinent.
Fig. 6 D schematically illustrates how the concentration
profiles of fibroblast-derived proangiogenic factors could be
altered at an early time point (t¼ 12 h) in a sparse rather than
dense matrix. Although transport would be relatively
efficient in a 2.5 mg/ml fibrin gel, transport of larger
proangiogenic factors such as VEGF165 (38.5 kDa), HGF (85
kDa), and MMP-2 (72 kDa (latent)) would be significantly
slower in a 10 mg/ml gel.
One caveat to interpreting the measurements of Deff is that
fluorescently conjugated dextran particles were used to
approximate physiological proteins. Comparing dextran to
proteins of the same molecular mass reveals differences in
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structure, charge, and susceptibility to matrix binding, which
are all likely to affect the transport of physiological proteins.
Dextran macromolecules have a very flexible, randomly
coiled structure that is easily hydrated, whereas proteins have
a more condensed structure. Thus, a protein of a comparable
molecular mass to dextran may possess a smaller RH (47).
Both the Wilke-Chang correlation and Stokes-Einstein
equation predict that molecular diffusivity is inversely
related to RH (20,21); however, the relative difference
between Deff measured in 2.5 mg/ml and 10 mg/ml fibrin
would be unchanged. Furthermore, the potentially smaller
RH would likely be countered by charge and binding
interactions between a protein and the fibrin matrix, inter-
actions that are not captured by the use of dextran (48). For
example, proangiogenic growth factors such as VEGF and
bFGF bind specifically to fibrin; greater concentrations of
fibrin serve to bind higher amounts of these growth factors
and further restrict their net transport through the matrix
(49,50). In addition, heparin-mediated binding of these
proteins, as well as HGF, to the matrix is also likely to slow
transport through the interstitium (51–53). Thus, when all of
these factors are taken into account, the overall difference in
Deff measured between 2.5 and 10 mg/ml matrices is
expected to be even more pronounced.
In summary, we have shown that increasing matrix
density reduces capillary network formation and that this
effect can be abrogated by distributing fibroblasts throughout
the matrix. The robust capillary networks that form in the
dense gel as a result of interstitial fibroblast distribution are
functional, as evidenced by the fact that on implantation they
anastomose with mouse vasculature and carry blood. Net-
work formation within dense gels occurs despite the fact that
distributed fibroblasts fail to upregulate their ability to
remodel the matrix in response to the denser microenvi-
ronment. Instead, enhanced diffusion of fibroblast-mediated
factors is likely responsible for the observed effect. Al-
though this result certainly does not rule out the contribu-
tions of matrix stiffness and ligand binding density in
mediating this morphogenetic process, we believe that our
data cast a prominent light on the role of diffusive transport
limitations associated with increased matrix density in regu-
lating angiogenesis and potentially other morphogenetic
processes.
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FIGURE 6 Proposed mechanism by which diffusion limitations imposed by denser matrices restrict angiogenic sprouting. Modeling concentration profiles
within the 3-D coculture system reveals that the time to achieve steady state is drastically altered with decreasedDeff as shown when (A) Deff¼ 106 cm2/s, (B)
Deff ¼ 107 cm2/s, and (C) Deff ¼ 108 cm2/s. Shaded lines indicate concentration profiles at 12-h intervals up to 1 week (hence, 14 total solid lines). (D)
Comparison of these results with those shown in Fig. 5 F suggests that a possible mechanism for the observed reduction in angiogenesis is the restricted
transport of proangiogenic factors as fibrin density increases. In sparse matrices (e.g., 2.5 mg/ml fibrin, left panel), transport of proangiogenic molecules
proceeds rapidly, facilitating robust sprouting, although their transport in denser matrices (e.g., 10 mg/ml fibrin, right panel) is restricted, resulting in reduced
capillary morphogenesis.
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